| 1 |
33176060 | Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity. | 2021 Feb |
1 |
| 2 |
30774881 | Syntheses of defined sulfated oligohyaluronans reveal structural effects, diversity and thermodynamics of GAG-protein binding. | 2019 Jan 21 |
1 |
| 3 |
30845788 | Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are "More Equal" than Others. | 2019 Mar 6 |
1 |
| 4 |
29173042 | Antithrombin conformational modulation by D-myo-inositol 3,4,5,6-tetrakisphosphate (TMI), a novel scaffold for the development of antithrombotic agents. | 2018 Nov |
1 |
| 5 |
25325940 | Production of size-defined heparosan, heparan sulfate, and heparin oligosaccharides by enzymatic depolymerization. | 2015 |
1 |
| 6 |
22315264 | Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | 2012 Feb |
1 |
| 7 |
22498748 | Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. | 2012 Jul 26 |
1 |
| 8 |
23152789 | On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. | 2012 |
1 |
| 9 |
18574264 | Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | 2008 Jun |
1 |
| 10 |
15743473 | Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis. | 2005 |
1 |
| 11 |
15957976 | Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes. | 2005 Jun |
1 |
| 12 |
15078125 | Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate. | 2004 |
2 |
| 13 |
15311269 | Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. | 2004 Sep |
1 |
| 14 |
15383472 | Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. | 2004 Sep |
1 |
| 15 |
21866614 | Glycol chitosan/heparin-immobilized gold-deposited iron oxide nanoparticles | 2004 |
1 |
| 16 |
12768169 | [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?]. | 2003 May |
1 |
| 17 |
12865952 | [Haemostaseological aspects of perioperative blood management]. | 2003 Jun |
1 |
| 18 |
12907439 | Heparin-induced substrate behavior of antithrombin Cambridge II. | 2003 Dec 1 |
1 |
| 19 |
12004255 | Antithrombin, heparin, and heparan sulfate. | 2002 May |
1 |
| 20 |
12010802 | Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. | 2002 Jun 1 |
3 |
| 21 |
12413592 | Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. | 2002 Jul 15 |
2 |
| 22 |
11323006 | Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. | 2001 Mar 15 |
1 |
| 23 |
10766996 | Novel mutation (E113X) of antithrombin III gene (AT3) in a woman with gestational recurrent thrombosis. | 2000 Apr 24 |
1 |
| 24 |
11006120 | Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III. | 2000 Sep 16 |
1 |
| 25 |
11776053 | Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber. | 2000 Aug |
3 |
| 26 |
10914239 | [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia]. | 1999 Mar 1 |
1 |
| 27 |
9515777 | The anti-inflammatory properties of antithrombin III: new therapeutic implications. | 1998 |
1 |
| 28 |
9662467 | Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation. | 1998 Apr |
2 |
| 29 |
9692954 | Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. | 1998 Jul 28 |
1 |
| 30 |
9713170 | The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III. | 1998 Jul |
1 |
| 31 |
9169007 | Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity. | 1997 May 15 |
1 |
| 32 |
8662679 | Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa. | 1996 May 31 |
1 |
| 33 |
8951806 | The pathogenesis and prevention of atherosclerosis. | 1996 Nov |
1 |
| 34 |
7757423 | Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide. | 1994 Nov |
1 |
| 35 |
7806495 | Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. | 1994 Dec 30 |
1 |
| 36 |
7841596 | Tissue factor pathway. | 1994 Sep |
1 |
| 37 |
8167338 | Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. | 1994 May 1 |
1 |
| 38 |
8186357 | An overview of the mechanism of action of antithrombin and its inherited deficiency states. | 1994 Jan |
1 |
| 39 |
7692967 | High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. | 1993 Nov 16 |
1 |
| 40 |
8331144 | Membrane chromatography for rapid purification of recombinant antithrombin III and monoclonal antibodies from cell culture supernatant. | 1993 Jun 4 |
1 |
| 41 |
8429008 | Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin. | 1993 Feb 15 |
1 |
| 42 |
8429040 | Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. | 1993 Feb 15 |
1 |
| 43 |
1566349 | The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys. | 1992 Apr |
2 |
| 44 |
1872461 | Venous and aortic porcine endothelial cells cultured under standardized conditions synthesize heparan sulfate chains which differ in charge. | 1991 Mar 2 |
1 |
| 45 |
2083865 | Physiology of blood coagulation. | 1990 |
1 |
| 46 |
2175954 | Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. | 1990 Sep 15 |
1 |
| 47 |
2851191 | An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition. | 1988 Oct 31 |
2 |
| 48 |
3218731 | Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin. | 1988 Oct |
4 |
| 49 |
3400080 | Interaction of abnormal antithrombin-III Toyama with cultured porcine aortic endothelial cells. | 1988 Apr 1 |
1 |
| 50 |
3581111 | Structural characterization of sulfated glycosaminoglycans by fast atom bombardment mass spectrometry: application to heparin fragments prepared by chemical synthesis. | 1987 Apr 1 |
1 |